Is ibrutinib a chemotherapy drug?

IbrutinibIbrutinib is not a chemotherapy drug. Ibrutinib is a targeted drug that inhibitsBrutontyrosine kinase(BTK)< /span>To work, BrutonTyrosine kinase is a key signaling molecule that plays a vital role in the survival of certain cancers, especially B cell leukemias and lymphomas. By blocking BTK, ibrutinib blocks signals that stimulate malignant cells to grow and divide out of control, triggering cancer cell death.

Ibrutinib is used to treat Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, and chronic graft-versus-host disease.

What is the difference between chemotherapy and targeted therapy?

Chemotherapy primarily targets the rapid division of cancer cells, so it kills rapidly dividing cells. ButSome normal cells also divide very quickly, which is why chemotherapy has a variety of side effects, such as mouth problems, low blood counts, and hair loss. Targeted therapies can identify other characteristics of cancer cells that differ from normal cells or are more active than normal cells. There are many different types of targeted therapies, each of which works slightly differently, but they all interfere with the ability of cancer cells to grow, divide, repair or communicate with other cells. Research continues to identify other cancer characteristics to target and figure out which cancers are best treated with targeted therapies. There are generic drugs in Bangladesh, Laos and India, with different manufacturers, different specifications, and different prices. The price per box is about 1000 to 2000. Patients can choose the drug version according to their own economic situation. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.